|
NDEL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.263800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.407200E-01 |
| Normal-vs-Stage2 |
4.178000E-01 |
| Normal-vs-Stage3 |
8.501200E-01 |
| Normal-vs-Stage4 |
1.501190E-01 |
| Stage1-vs-Stage2 |
2.244400E-01 |
| Stage1-vs-Stage3 |
6.486000E-01 |
| Stage1-vs-Stage4 |
1.515610E-01 |
| Stage2-vs-Stage3 |
4.340600E-01 |
| Stage2-vs-Stage4 |
5.462000E-01 |
| Stage3-vs-Stage4 |
2.415400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.189600E-01 |
| Normal-vs-AfricanAmerican |
9.210800E-01 |
| Normal-vs-Asian |
6.603400E-01 |
| Caucasian-vs-AfricanAmerican |
3.730200E-01 |
| Caucasian-vs-Asian |
9.965600E-01 |
| AfricanAmerican-vs-Asian |
7.446400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.753400E-01 |
| Normal-vs-Female |
3.750400E-01 |
| Male-vs-Female |
8.183200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.616200E-01 |
| Normal-vs-Extreme_Weight |
4.851400E-01 |
| Normal-vs-Obese |
1.566440E-01 |
| Normal-vs-Extreme_Obese |
9.997000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.585800E-02 |
| Normal_Weight-vs-Obese |
1.754440E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.057600E-01 |
| Extreme_Weight-vs-Obese |
5.060000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.520000E-01 |
| Obese-vs-Extreme_Obese |
4.737600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.338400E-02 |
| Normal-vs-Age(41-60Yrs) |
4.961900E-02 |
| Normal-vs-Age(61-80Yrs) |
7.594600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.857750E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.298600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.054350E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.900300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.679400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.158100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.865030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.135600E-03 |
| Normal-VS-Type2 PRCC |
8.218400E-03 |
| Normal-VS-KIRP CIMP |
9.515600E-02 |
| Normal-VS-Unclassified PRCC |
8.469600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.29600055318735E-10 |
| Type1 PRCC-VS-KIRP CIMP |
3.683600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.592300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.842180E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
8.600000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.399500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.188200E-01 |
| Normal-vs-N1 |
9.321600E-01 |
| Normal-vs-N2 |
7.803900E-02 |
| N0-vs-N1 |
1.913180E-01 |
| N0-vs-N2 |
4.250200E-01 |
| N1-vs-N2 |
1.977720E-02 |
|
|
